We are pleased to announce that Isoprotrace®, our kit for preparation of Gallium-68 Gozetotide, has received official approval for sale in the Netherlands. This milestone represents a significant advancement in our commitment to delivering innovative solutions for cancer.
About Isoprotrace®
Isoprotrace® is a PSMA-11 (also know as Gozetotide) radiolabelling kit specifically designed for prostate cancer imaging. This ready-to-use, multi-dose kit allows for the efficient preparation of Gallium (68Ga) Gozetotide solution for I.V. injection. For detailed indications, please refer to the product’s SmPC.
Partnership for Accessibility
In collaboration with PI Medical, our trusted distributor in the Netherlands, we ensure widespread availability of Isoprotrace® across medical facilities in the region. This partnership also extends to the distribution of our Lutetium 177 n.c.a., further enhancing our portfolio of advanced cancer imaging and treatment solutions.
The Impact on Prostate Cancer Care
Prostate cancer remains a significant health concern globally. Accurate imaging plays a crucial role in early detection, precise diagnosis, and effective treatment planning.
Learn More
For detailed information about Isoprotrace® and its applications in prostate cancer imaging, please contact PI Medical or reach out to us directly. Our team stands ready to provide support, answer your questions, and arrange product demonstrations.
Our Commitment
At Isotopia our mission is to deliver better patient outcomes by innovating and enhancing diagnostic and therapeutic capabilities in the fight against cancer through advanced medical imaging solution.
Stay tuned for more updates as we continue to expand the availability of Isoprotrace® to other regions, furthering our impact on global healthcare.
